The DOI matches its Crossref record.
Pharmacological basis for the use of nimodipine in central nervous system disorders
Abstract
Nimodipine, a Ca 2+ antagonist with cerebrovasodilatory and anti‐ischemic effects, binds to rat, guinea pig, and human brain membranes with high affinity (less than 1 nM). Only at higher concentrations has nimodipine been reported to block the release of some neurotransmitters and hormones from neuronal tissue. Nimodipine has no consistent effect on brain oxygen consumption or cortical ATP or phosphocreatine levels, although the ischemia‐induced fall of brain ATP levels in gerbils or the lowering of intracellular brain pH in rabbits with focal cerebral ischemia were antagonized by the drug. In rats and baboons with middle cerebral artery occlusion, nimodipine was found to reduce neurological deficits without an increase in intracranial pressure or brain edema. Electrophysiological studies with nimodipine suggested a direct neuronal action. In rabbit dorsal root ganglion cells, concentrations as low as 20 nM were reported to block inward Ca 2+ currents. Recent studies have suggested that nimodipine may also improve memory in brain‐damaged or old rats, restore sensorimotor function and abnormal walking patterns of old rats, and accelerate acquisition of associative learning in aging rabbits. Blockade of age‐related changes in Ca 2+ fluxes in rat hippocampal neurones by nimodipine in vitro pointed to neuronal plasma membrane as the site of nimodipine action. The therapeutic usefulness of nimodipine appears not to be limited to cerebral ischemia, but may include dementia, age‐related degenerative diseases, epilepsy, and ethanol intoxication.—S criabine , A.; S chuurman , T.; T raber , J. Pharmacological basis for the use of nimodipine in central nervous system disorders. FASEB J. 3: 1799‐1806; 1989.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Phantom auditory perception (tinnitus): mechanisms of generation and perception
Jastreboff, P. J. (1990) · Neuroscience Research · doi:10.1016/0168-0102(90)90031-9 · Cited by 1,576
Cerebral microvascular pathology in aging and Alzheimer's disease
Farkas, E., & Luiten, P. G. M. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00068-x · Cited by 1,102
Neuroprotection for ischemic stroke: Past, present and future
Ginsberg, M. D. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.12.007 · Cited by 779
Impact of aging on hippocampal function: plasticity, network dynamics, and cognition
Rosenzweig, E. S., & Barnes, C. A. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00126-0 · Cited by 733
Increase in Single L-Type Calcium Channels in Hippocampal Neurons During Aging
Thibault, O., & Landfield, P. W. (1996) · Science · doi:10.1126/science.272.5264.1017 · Cited by 497
Metadata
- Authors
- Scriabine, A., Schuurman, T., & Traber, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 1989-05
- Volume
- 3
- Issue
- 7
- Pages
- 1799-1806
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W1565992055
- Cited by
- 247
- References
- 0
- FWCI
- 12.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacological basis for the use of nimodipine in central nervous system disorders. https://app.cochat.ai/papers/10.1096/fasebj.3.7.2565839
- The paper
- Scriabine, A., Schuurman, T., & Traber, J. (1989). Pharmacological basis for the use of nimodipine in central nervous system disorders. The FASEB Journal. https://doi.org/10.1096/fasebj.3.7.2565839
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.